RT Journal Article
SR Electronic
T1 Woven EndoBridge device for ruptured aneurysms: perioperative results of a US multicenter experience
JF Journal of NeuroInterventional Surgery
JO J NeuroIntervent Surg
FD BMJ Publishing Group Ltd.
SP 1012
OP 1016
DO 10.1136/neurintsurg-2020-017105
VO 13
IS 11
A1 Cortez, Gustavo M
A1 Akture, Erinc
A1 Monteiro, Andre
A1 Arthur, Adam S
A1 Peterson, Jeremy
A1 Dornbos, David
A1 Jabbour, Pascal
A1 Gooch, M Reid
A1 Sweid, Ahmad
A1 Tjoumakaris, Stavropoula I
A1 Delgado Almandoz, Josser E
A1 Kayan, Yasha
A1 Rai, Ansaar T
A1 Boo, SoHyun
A1 Fiorella, David
A1 Vachhani, Jay
A1 Foreman, Paul
A1 Cress, Marshall
A1 Siddiqui, Adnan H
A1 Waqas, Muhammad
A1 Aghaebrahim, Amin
A1 Sauvageau, Eric
A1 Hanel, Ricardo A
YR 2021
UL http://jnis.bmj.com/content/13/11/1012.abstract
AB Background The Woven EndoBridge (WEB) device is approved in the USA for treatment of unruptured wide-neck bifurcation aneurysms. However, the safety and effectiveness of the WEB device in the treatment of ruptured intracranial aneurysms is not clear. We aim to evaluate the perioperative safety and effectiveness of the WEB device in patients with ruptured intracranial aneurysms.Methods This retrospective study, conducted at eight centers in the USA, included patients with ruptured intracranial aneurysms treated with the WEB device in the setting of subarachnoid hemorrhage (SAH). Safety outcomes included intraoperative complications such as vessel perforation, thromboembolic events, and postoperative hemorrhagic or thromboembolic complications based on radiologic imaging. The primary effectiveness outcome was adequate (complete and neck remnant) aneurysm occlusion, according to the Raymond–Roy classification.Results A total of 91 patients with 94 ruptured intracranial aneurysms were included (mean age 57.7±15.2 years; 68.1% women; 82.9% wide-necked). Aneurysms were located in the anterior communicating artery (42/94, 44.6%), middle cerebral artery (16/94, 17%), and basilar artery (15/94, 16%). Adequate occlusion was achieved in 48.8% (41/84) and 80.0% (40/50) at discharge and last follow-up (mean of 3.4 months), respectively. At discharge, procedural-related morbidity was 3.3% (3/91) and there was no procedure-related mortality. No re-rupture or delayed aneurysm rupture was observed.Conclusions This study demonstrates the perioperative safety and effectiveness of the WEB device for the treatment of patients with ruptured intracranial aneurysms in the setting of SAH, with low periprocedural morbidity and mortality. Long-term follow-up is warranted.Data are available upon reasonable request.